Cardiomyopathies Clinical Trials in London
2 recruitingLondon, United Kingdom
Showing 1–2 of 2 trials
Recruiting
Phase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
CardiomyopathiesAmyloidosisHeart Diseases+3 more
Eidos Therapeutics, a BridgeBio company582 enrolled94 locationsNCT06563895
Recruiting
Not Applicable
Therapy to Maintain Remission in Dilated Cardiomyopathy
Heart FailureCardiomyopathiesHeart Diseases+1 more
Imperial College London50 enrolled1 locationNCT06091475